Journals / The Anatolian Journal of Cardiology / 2018 / Cilt: 20 - Sayı: 1

Prognostic impact of renal dysfunction on long-term mortality in patients with preserved, moderately impaired, and severely impaired left ventricular systolic function following myocardial infarction

Pages
21–28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the Mulivariate Cox Analysis, RD remained an independent predictor of 6-year mortalityin patients with moderately (HR 2.52, 95% CI 1.54-3.78) and severely impaired systolic function (HR 2.84, 95% CI 1.68-5.34), but not in patientswith preserved left ventricular systolic function (HR 0.59, 95% CI 0.14-1.41).Conclusion: Although patients with RD had higher 6-year mortallity following STEMI regardless of LVEF, RD at admission remained a strongindependent predictor for 6-year mortality only in patients with moderately and severely impaired left ventricular systolic function.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to investigate and compare the prognostic impact of renal dysfunction (RD) at admission in patients withpreserved, moderately impaired and severely impaired left ventricular systolic function following ST-elevation myocardial infarction (STEMI).Methods: We included 2436 patients with STEMI treated with primary percutaneous coronary intervention (pPCI).
📊
Key Findings & Data:According to the left ventricular ejection fraction (EF), patients were divided inthree groups: preserved left ventricular systolic function – EF >50%, moderately impaired – EF=40%-50% and severely impaired left ventricularsystolic function-EF <40%.
💡
Conclusion & Impact:In the Mulivariate Cox Analysis, RD remained an independent predictor of 6-year mortalityin patients with moderately (HR 2.52, 95% CI 1.54-3.78) and severely impaired systolic function (HR 2.84, 95% CI 1.68-5.34), but not in patientswith preserved left ventricular systolic function (HR 0.59, 95% CI 0.14-1.41).Conclusion: Although patients with RD had higher 6-year mortallity following STEMI regardless of LVEF, RD at admission remained a strongindependent predictor for 6-year mortality only in patients with moderately and severely impaired left ventricular systolic function.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The aim of this study was to investigate and compare the prognostic impact of renal dysfunction (RD) at admission in patients withpreserved, moderately impaired and severely impaired left ventricular systolic function following ST-elevation myocardial infarction (STEMI).Methods: We included 2436 patients with STEMI treated with primary percutaneous coronary intervention (pPCI). Patients presenting withcardiogenic shock and those on hemodyalisis were excluded. According to the left ventricular ejection fraction (EF), patients were divided inthree groups: preserved left ventricular systolic function – EF >50%, moderately impaired – EF=40%-50% and severely impaired left ventricularsystolic function-EF <40%. RD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2 at admission. The follow-up periodwas 6 years.Results: Preserved, moderately impaired and severely impaired systolic function were found in 741 (30.5%), 1367 (56.1%) and 328 (13.4%) patients,respectively. RD was present in 105 (14.2%) patients with preserved systolic function, 247 (18.1%) patients with moderately impaired, and120 (36.5%) patients with severely impaired systolic function.Regardless of the presence of RD, 6-year mortality rates in patients with preserved,moderately impaired, and severely impaired systolic function were 2.7%, 5.2% and 31.1% respectively. Within each LVEF group, patients with RDhad a worse outcome, both in the short- and long-term. In the Mulivariate Cox Analysis, RD remained an independent predictor of 6-year mortalityin patients with moderately (HR 2.52, 95% CI 1.54-3.78) and severely impaired systolic function (HR 2.84, 95% CI 1.68-5.34), but not in patientswith preserved left ventricular systolic function (HR 0.59, 95% CI 0.14-1.41).Conclusion: Although patients with RD had higher 6-year mortallity following STEMI regardless of LVEF, RD at admission remained a strongindependent predictor for 6-year mortality only in patients with moderately and severely impaired left ventricular systolic function.

🔖

Cite This Article

SAVİC, L., MRDOVİC, I., ASANİN, M., STANKOVİC, S., KRLJANAC, G., LASİCA, R. (2018). Prognostic impact of renal dysfunction on long-term mortality in patients with preserved, moderately impaired, and severely impaired left ventricular systolic function following myocardial infarction. The Anatolian Journal of Cardiology, Cilt: 20 - Sayı: 1, 21–28. https://ajindex.com/articles/365331

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Ekmekci A, Uluganyan M, Gungor B, Tufan F, Cekirdekci EI, Ozcan KS, et al. Comparison of Cockroft-Gault and Modification of Diet in Renal Disease Formulas as predictors of cardiovascular outcomes in patients with myocardial infarction treated with primary percutaneous coronary intervention. Angiology 2014; 65: 838-43. [CrossRef] Ter Maaten JM, Damman K, Verhaar MC, Paulus WJ, Duncker DJ, Cheng C, et al. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail 2016; 18: 588-98. [CrossRef] McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, BayesGenis A, et al.; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula. Circ Heart Fail 2012; 5: 309-14. [CrossRef] Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 37: 2129-200. [CrossRef] Lam CS, Solomon SD. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%). Eur J Heart Fail 2014; 16: 1049-55. [CrossRef] Mrdovic I, Savic L, Lasica R, Krljanac G, Asanin M, Brdar N, et al. Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register. Eur Heart J Acute Cardiovas Care 2014; 3: 56-66.
  2. Löfman I, Szummer K, Dahlström U, Jernberg T, Lund LH. Association with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Eur J Heart Fail 2017; 19: 1606-14. [CrossRef] Nauta JF, Hummel YM, van Melle JP, van der Meer P, Lam CSP, Ponikowski P, et al. What have we learned about heart failure with midrange ejection fraction one year after its introduction? Eur J Heart Fail 2017; 19: 1569-73. [CrossRef] Marenzi G, Moltrasio M, Assanelli E, Lauri G, Marana I, Grazi M, et al. Impact of cardiac and renal